Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Observational Study to Describe the Performance of Caris Chromoseq as Compared to Conventional Cytogenetics, FISH, and NGS Testing Among Patients Receiving the Caris Chromoseq Assay for Hematologic Malignancies

NCT07680868 is registered in ClinicalTrials.gov with Caris Science, Inc. as lead sponsor.

NCT NCT07680868
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07680868 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Observational Study to Describe the Performance of Caris Chromoseq as Compared to Conventional Cytogenetics, FISH, and NGS Testing Among Patients Receiving the Caris Chromoseq Assay for Hematologic Malignancies
Lead sponsor
Caris Science, Inc.
Phase
Observational
Overall status
Recruiting
Start date
July 31, 2026
Completion date
July 31, 2029
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute myeloid leukemia (aml), myelodysplastic (mds) / myeloproliferative (mpn) diseases, myelodysplatic syndromes, myeloproliferative neoplasm